Live webcast will be at 8:30 a.m. EST on January 25OXFORD, United Kingdom, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Vaccitech...
InteliSwab test With less than one minute of “hands-on time,” the InteliSwab test is as simple as “Swab, Swirl, and...
Mechelen, Belgium; 13 January 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its supervisory...
-A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- -REVTx-99 was tested prior to infection in multiple...
TUCSON, Ariz., Jan. 13, 2022 (GLOBE NEWSWIRE) -- In response to calls for doubling down on costly failed public health...
Veranome expands its spatial omics intellectual property portfolio into unbiased in-situ sequencing to address a broader set of applications with...
A return to growth in direct sales of Safe OrthopaedicsSafe Medical annual sales up 50% Cash position of €0.9M and...
This Study performs unique rapid on-site measurement using patient whole blood and positions Company to move forward with multiple initiativesACTON,...
myAir Launches AI System For Natural Stress Management myAir Insights combines functional, plant-based nutrition with data-driven technology to create a...
Promising New Approach for a Fatal Neurological DisorderGUILFORD, Conn., Jan. 13, 2022 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage...
SAN DIEGO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today Sorrento Therapeutics Mexico (“Sorrento...
Data confirm strong anticancer activity of two lead compounds in CT-01 programResults support advancement of CT-01 compounds towards IND expected...
-- DAYBREAK is the most comprehensive Phase 2 trial ever initiated in rare genetic diseases of obesity ---- DAYBREAK is...
– New commitment from the Bill & Melinda Gates Foundation supports the development of Vir’s novel “vaccinal antibody” technology as another...
Amendment and restatement of existing Master Facility License Agreement is to continue the establishment and operations of micro-clinics in Canada...
KITCHENER, ON / ACCESSWIRE / January 13, 2022 / Cloud DX Inc. ("Cloud DX" or the "Company") (TSXV:CDX) announces that...